Press releases - Hamlet BioPharma

Press releases

Oct

05

2023

Hamlet BioPharma will be presenting at Aktiedagen, Aktiespararna, on Monday, October 9th, in Lund at 12:10 CET

Hamlet Biopharma

|

Hamlet BioPharma is inviting you to join a presentation at Aktiedagen, Aktiespararna, on Monday October 9th at 12.10 CET, Elite Hotel Ideon, Lund. The...

Read more

Aug

11

2023

Kommuniké Från Extra Bolagsstämman i Hamlet Pharma AB

Hamlet Biopharma

|

Pressmeddelande, Malmö 11 augusti 2023 Som tidigare meddelats har Bolagsverket registrerat fusionen mellan Hamlet Pharma och SelectImmune Pharma. Dett...

Read more

1
2
3
4

Recent posts

Pressrelease – Lund, October 8th 2026 – Alpha1H builds its scientific case as Phase III gets under way

October 8, 2026

Pressrelease – Lund, September 24th 2026 – Hamlet Biopharma Is Profiled On ‘’The Bio Report’’, One Of The Leading Biotech Podcasts In The World

September 24, 2026

Pressrelease – Lund, September 21st 2026 – BAMLET treatment strengthens metabolic health – nutrition as a first step toward commercialization

September 21, 2026

Pressrelease – Lund, September 21st 2026 – Hamlet BioPharma’s monthly digital investors’ meeting on September 23rd

September 21, 2026

An innovative pharmaceutical company with a broad and strong portfolio of projects for the treatment of cancer and infections.

Hamlet BioPharma AB
Klinikgatan 32
SE-222 42 Lund
info@hamletbiopharma.com
Org. no. 556568-8958

Subscribe to receive
Pressreleases and Newsletters

© 2026

Hamlet BioPharma.